Tempus Wealth Planning, LLC Alvotech Transaction History
Tempus Wealth Planning, LLC
- $360 Million
- Q2 2025
A detailed history of Tempus Wealth Planning, LLC transactions in Alvotech stock. As of the latest transaction made, Tempus Wealth Planning, LLC holds 31,652 shares of ALVO stock, worth $267,142. This represents 0.08% of its overall portfolio holdings.
Number of Shares
31,652
Previous 24,680
28.25%
Holding current value
$267,142
Previous $238,000
21.01%
% of portfolio
0.08%
Previous 0.08%
Shares
3 transactions
Others Institutions Holding ALVO
# of Institutions
48Shares Held
15.8MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA4.19MShares$35.4 Million0.0% of portfolio
-
Bracebridge Capital, LLC2.71MShares$22.8 Million20.4% of portfolio
-
Howard Marks Oaktree Capital Management LP | Los Angeles, Ca1.87MShares$15.8 Million0.54% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD1.4MShares$11.8 Million0.0% of portfolio
-
Littlejohn & CO LLC1.32MShares$11.1 Million6.46% of portfolio
About Alvotech
- Ticker ALVO
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 248,650,000
- Market Cap $2.1B
- Description
- Alvotech, through its subsidiaries, develops and manufactures biosimilar medicines for patients worldwide. It offers biosimilar products in the therapeutic areas of autoimmune, eye, and bone disorders, as well as cancer. The company's lead program is AVT02, a high concentration formulation biosimilar to Humira to treat various inflammatory condi...